久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

愛沙尼亞CeMines 
生命科學和生物技術領域的新專家，專業提供分子研究工具、診斷產品、先進療法（如將基因功能研究應用于癌癥療法）
CeMines was founded in 2000 by Richard Cavalli, Dr. Toomas Neuman, Ph.D. and Dr. Kaia Palm, Ph.D. to develop cancer diagnostics using two methods: auto-antibody and splice variants.

Our focus is on the early, and accurate detection of Cancer within the human body with an initial product focus on Lung Cancer.

We are creating molecular diagnostics for cancer based on a simple blood test. This method analyzes a drop of blood for the presence of antibodies your body produces to fight cancer. Our approach identifies cancer before it spreads and provides a preventative measure for “at-risk” populations.

Our R&D is focused on diagnostic tests for lung, breast, gastrointestinal and leukemia. In addition to cancer, however, our science has applications for Immune disorders such as Hepatitis C, HIV and Rheumatoid Arthritis. We are also extending our methods to transplant donor matching applications.

CeMines Corporate Headquarters is in Golden, Colorado and our Scientific Laboratories are in Tallinn, Estonia.